-
Mashup Score: 4
Viral Shah, MD, joins Diabetes Dialogue to discuss a recent study examining associations between time in range and other advanced CGM metrics with diabetic retinopathy and the implications for use in predicting other microvascular outcomes.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Diabetes Dialogue: 2023 Top Episodes Recap - 12 month(s) ago
To celebrate the end of 2023, hosts recap the top 10 episodes of the past year and offer perspective on how the news discussed in these episodes has shaped the future of diabetes management.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 5
In this episode, hosts discuss the FDA clearance of the Omnipod 5 App for iPhones and a pair of studies examining use of automated insulin delivery systems.
Source: www.hcplive.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 0Diabetes Dialogue: Reforming Language in Metabolic Disease, with Jane Dickinson, RN, PhD - 1 year(s) ago
At ADA 2023, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sat down with ADCES President-Elect Jane Dickinson, RN, PhD, to discuss her work to address shortfalls of the current language used in the management of diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: Tandem Mobi and Welldoc's BlueStar Platform - 1 year(s) ago
In this episode, hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: Tandem Mobi and Welldoc's BlueStar Platform - 1 year(s) ago
In this episode, hosts discuss their experience interacting with the Tandem Mobi pump from the ADCES 2023 meeting and offer perspective on what the Welldoc clearances mean for people with diabetes and care providers.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 4
In this special edition episode, hosts break down what the announcement of the 10 drugs selected for Medicare price negotiations under the Inflation Reduction Act means for providers and people with diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Diabetes Dialogue: STEP-HFpEF Reaction - 1 year(s) ago
Less than 2 weeks after the release of their SELECT reaction podcast, hosts Diana Isaacs, PharmD, and Natalie Bellini, DNP, sit down for a special edition episode of Diabetes Dialogue to discuss STEP-HFpEF data and the implications for semaglutide 2.4 mg.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD - 1 year(s) ago
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of individualizing nutrition in diabetes management, and the sessions she led and moderated at ADCES 2023.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Diabetes Dialogue: The Role of Nutrition in Diabetes Management, with Dawn Noe, RDN, LD - 1 year(s) ago
In this episode, Isaacs and Bellini sit down with Dawn Noe, RDN, LD, for a discussion surrounding her journey into diabetes care, the importance of individualizing nutrition in diabetes management, and the sessions she led and moderated at ADCES 2023.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
The latest #DiabetesDialogue is now live! Learn more about the utility of time in range and other advanced CGM metrics with @DianaMIsaacs and @Natalie_Bellini as well as @DrViralShah. https://t.co/OMOOS781pI https://t.co/PtklxRLj5r